ADB’s Rapid COVID-19 Response in Southeast Asia

Publication | June 2021

This brochure provides an overview of how ADB is assisting its developing member countries in Southeast Asia to combat the COVID-19 pandemic.

ADB has approved $5.813 billion in financing to help Southeast Asian countries cope with the devastating impacts of the pandemic. This support focuses on three key areas: boosting healthcare responses, enhancing social protection, and protecting businesses and economies. Recent assistance to Indonesia and the Philippines was also provided to support COVID-19 vaccine procurement and distribution under ADB’s Asia Pacific Vaccine Access Facility (APVAX).

The brochure provides details on how and where this assistance is being rolled out and includes country-specific examples. It also looks at ADB’s collaboration with the private sector and development partners, and the complementary support being provided through its knowledge and policy advice services.

Additional Details

  • ADB funds and products
  • Health
  • Communicable and vector-borne diseases
  • Emerging diseases
  • COVID-19
  • Health finance
  • Private sector development
  • Cambodia
  • Indonesia
  • Lao People's Democratic Republic
  • Myanmar
  • Philippines
  • Singapore
  • Thailand
  • Timor-Leste
  • Viet Nam
  • 10
  • 11 x 8.5
  • ARM210162-2

Subscribe to our monthly digest of latest ADB publications.

Follow ADB Publications on social media.